For years, women using hormone therapy have faced confusing—and often frightening—messaging about estrogen safety. One of the biggest sources of anxiety was the Black Box Warning (BBW) placed on estradiol products, which suggested increased risks of heart disease, stroke, and certain cancers. But in a major step toward accuracy and patient reassurance, the FDA has now removed the Black Box Warning for estradiol. This change reflects updated evidence about hormone therapy and
